Base-case analysis
| Parameter | China | United States | ||||
| Alteplase | Placebo | Difference | Alteplase | Placebo | Difference | |
| Costs | ¥122 223 | ¥111 623 | ¥9552 | US$151 442 | US$153 465 | US$−2024 |
| QALY | 3.474 | 3.348 | 0.126 | 4.758 | 4.566 | 0.193 |
| ICER | 83 950 | Negative | ||||
ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year; US, United States.